Incidence and risk factors for acute kidney injury in head and neck cancer patients treated with concurrent chemoradiation with high-dose cisplatin

Table 3 Renal Function

Renal function, mean sCr, μmol/l (SD)
Time point	AKI	Non-AKI	p value²
Baseline	66 (12)	65 (12)	0.78
3 months	103 (36)	79 (14)	0.001
p value¹	0.001	0.01	0.001
12 months	100 (35)	80 (21)	0.01
p value¹	0.002	0.01	0.01

Abbreviations: sCr serum creatinine, SD standard deviation; p¹, intra-group comparison of renal function to baseline sCr; p², intergroup comparison of renal function

ISSN: 1471-2407